Literature DB >> 33083687

Digital Measures That Matter to Patients: A Framework to Guide the Selection and Development of Digital Measures of Health.

Christine Manta1,2, Bray Patrick-Lake1,3, Jennifer C Goldsack1.   

Abstract

BACKGROUND: With the rise of connected sensor technologies, there are seemingly endless possibilities for new ways to measure health. These technologies offer researchers and clinicians opportunities to go beyond brief snapshots of data captured by traditional in-clinic assessments, to redefine health and disease. Given the myriad opportunities for measurement, how do research or clinical teams know what they should be measuring? Patient engagement, early and often, is paramount to thoughtfully selecting what is most important. Regulators encourage stakeholders to have a patient focus but actionable steps for continuous engagement are not well defined. Without patient-focused measurement, stakeholders risk entrenching digital versions of poor traditional assessments and proliferating low-value tools that are ineffective, burdensome, and reduce both quality and efficiency in clinical care and research.
SUMMARY: This article synthesizes and defines a sequential framework of core principles for selecting and developing measurements in research and clinical care that are meaningful for patients. We propose next steps to drive forward the science of high-quality patient engagement in support of measures of health that matter in the era of digital medicine. KEY MESSAGES: All measures of health should be meaningful, regardless of the product's regulatory classification, type of measure, or context of use. To evaluate meaningfulness of signals derived from digital sensors, the following four-level framework is useful: Meaningful Aspect of Health, Concept of Interest, Outcome to be measured, and Endpoint (exclusive to research). Incorporating patient input is a dynamic process that requires more than a single, transactional touch point but rather should be conducted continuously throughout the measurement selection process. We recommend that developers, clinicians, and researchers reevaluate processes for more continuous patient engagement in the development, deployment, and interpretation of digital measures of health.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Digital measures; Digital medicine; Patient engagement

Year:  2020        PMID: 33083687      PMCID: PMC7548919          DOI: 10.1159/000509725

Source DB:  PubMed          Journal:  Digit Biomark        ISSN: 2504-110X


  14 in total

Review 1.  Digital Medicine: A Primer on Measurement.

Authors:  Andrea Coravos; Jennifer C Goldsack; Daniel R Karlin; Camille Nebeker; Eric Perakslis; Noah Zimmerman; M Kelley Erb
Journal:  Digit Biomark       Date:  2019-05-09

2.  Low-Load Resistance Training With Blood-Flow Restriction in Relation to Muscle Function, Mass, and Functionality in Women With Rheumatoid Arthritis.

Authors:  Reynaldo Rodrigues; Rodrigo B Ferraz; Ceci O Kurimori; Lissiane K Guedes; Fernanda R Lima; Ana L de Sá-Pinto; Bruno Gualano; Hamilton Roschel
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05-14       Impact factor: 4.794

3.  Cognitive associations with comprehensive gait and static balance measures in Parkinson's disease.

Authors:  Rosie Morris; Douglas N Martini; Katrijn Smulders; Valerie E Kelly; Cyrus P Zabetian; Kathleen Poston; Amie Hiller; Kathryn A Chung; Laurice Yang; Shu-Ching Hu; Karen L Edwards; Brenna Cholerton; Thomas J Grabowski; Thomas J Montine; Joseph F Quinn; Fay Horak
Journal:  Parkinsonism Relat Disord       Date:  2019-07-04       Impact factor: 4.891

4.  Wearable Sensors in Huntington Disease: A Pilot Study.

Authors:  Kelly L Andrzejewski; Ariel V Dowling; David Stamler; Timothy J Felong; Denzil A Harris; Cynthia Wong; Hang Cai; Ralf Reilmann; Max A Little; Joseph T Gwin; Kevin M Biglan; E Ray Dorsey
Journal:  J Huntingtons Dis       Date:  2016-06-18

5.  Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force.

Authors:  Marc K Walton; John H Powers; Jeremy Hobart; Donald Patrick; Patrick Marquis; Spiros Vamvakas; Maria Isaac; Elizabeth Molsen; Stefan Cano; Laurie B Burke
Journal:  Value Health       Date:  2015-08-24       Impact factor: 5.725

6.  Criterion Validity of the activPAL Activity Monitor for Sedentary and Physical Activity Patterns in People Who Have Rheumatoid Arthritis.

Authors:  Louise Larkin; Birgitta Nordgren; Helen Purtill; Charles Brand; Alexander Fraser; Norelee Kennedy
Journal:  Phys Ther       Date:  2015-12-04

7.  A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network.

Authors:  Alaina P Boyer; Alecia M Fair; Yvonne A Joosten; Rowena J Dolor; Neely A Williams; Lisa Sherden; Sarah Stallings; Duane T Smoot; Consuelo H Wilkins
Journal:  Med Care       Date:  2018-10       Impact factor: 2.983

Review 8.  Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010-2016: A Systematic Literature Review.

Authors:  Brian Perry; Will Herrington; Jennifer C Goldsack; Cheryl A Grandinetti; Kaveeta P Vasisht; Martin J Landray; Lauren Bataille; Robert A DiCicco; Corey Bradley; Ashish Narayan; Elektra J Papadopoulos; Nirav Sheth; Ken Skodacek; Komathi Stem; Theresa V Strong; Marc K Walton; Amy Corneli
Journal:  Digit Biomark       Date:  2018-01-31

Review 9.  Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs).

Authors:  Jennifer C Goldsack; Andrea Coravos; Jessie P Bakker; Brinnae Bent; Ariel V Dowling; Cheryl Fitzer-Attas; Alan Godfrey; Job G Godino; Ninad Gujar; Elena Izmailova; Christine Manta; Barry Peterson; Benjamin Vandendriessche; William A Wood; Ke Will Wang; Jessilyn Dunn
Journal:  NPJ Digit Med       Date:  2020-04-14

Review 10.  Modernizing and designing evaluation frameworks for connected sensor technologies in medicine.

Authors:  Andrea Coravos; Megan Doerr; Jennifer Goldsack; Christine Manta; Mark Shervey; Beau Woods; William A Wood
Journal:  NPJ Digit Med       Date:  2020-03-13
View more
  14 in total

1.  The Path Forward for Digital Measures: Suppressing the Desire to Compare Apples and Pineapples.

Authors:  Carrie R Houts; Bray Patrick-Lake; Ieuan Clay; R J Wirth
Journal:  Digit Biomark       Date:  2020-11-26

2.  Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball.

Authors:  Hiromasa Mori; Stig Johan Wiklund; Jason Yuren Zhang
Journal:  Digit Biomark       Date:  2022-06-29

Review 3.  Considerations for Conducting Bring Your Own "Device" (BYOD) Clinical Studies.

Authors:  Charmaine Demanuele; Cynthia Lokker; Krishna Jhaveri; Pirinka Georgiev; Emre Sezgin; Cindy Geoghegan; Kelly H Zou; Elena Izmailova; Marie McCarthy
Journal:  Digit Biomark       Date:  2022-07-04

4.  A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.

Authors:  Florian Lipsmeier; Cedric Simillion; Atieh Bamdadian; Rosanna Tortelli; Lauren M Byrne; Yan-Ping Zhang; Detlef Wolf; Anne V Smith; Christian Czech; Christian Gossens; Patrick Weydt; Scott A Schobel; Filipe B Rodrigues; Edward J Wild; Michael Lindemann
Journal:  J Med Internet Res       Date:  2022-06-28       Impact factor: 7.076

Review 5.  Evaluation, Acceptance, and Qualification of Digital Measures: From Proof of Concept to Endpoint.

Authors:  Jennifer C Goldsack; Ariel V Dowling; David Samuelson; Bray Patrick-Lake; Ieuan Clay
Journal:  Digit Biomark       Date:  2021-03-23

Review 6.  Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.

Authors:  Diane Stephenson; Robert Alexander; Varun Aggarwal; Reham Badawy; Lisa Bain; Roopal Bhatnagar; Bastiaan R Bloem; Babak Boroojerdi; Jackson Burton; Jesse M Cedarbaum; Josh Cosman; David T Dexter; Marissa Dockendorf; E Ray Dorsey; Ariel V Dowling; Luc J W Evers; Katherine Fisher; Mark Frasier; Luis Garcia-Gancedo; Jennifer C Goldsack; Derek Hill; Janice Hitchcock; Michele T Hu; Michael P Lawton; Susan J Lee; Michael Lindemann; Ken Marek; Nitin Mehrotra; Marjan J Meinders; Michael Minchik; Lauren Oliva; Klaus Romero; George Roussos; Robert Rubens; Sakshi Sadar; Joseph Scheeren; Eiichi Sengoku; Tanya Simuni; Glenn Stebbins; Kirsten I Taylor; Beatrice Yang; Neta Zach
Journal:  Digit Biomark       Date:  2020-11-26

7.  Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future Directions.

Authors:  W Benjamin Nowell; Peter A Merkel; Robert N McBurney; Kalen Young; Shilpa Venkatachalam; Dianne G Shaw; Angela Dobes; Emily Cerciello; Laura Kolaczkowski; Jeffrey R Curtis; Michael D Kappelman
Journal:  Patient       Date:  2021-04-27       Impact factor: 3.883

Review 8.  EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration.

Authors:  Christine Manta; Nikhil Mahadevan; Jessie Bakker; Simal Ozen Irmak; Elena Izmailova; Siyeon Park; Jiat-Ling Poon; Santosh Shevade; Sarah Valentine; Benjamin Vandendriessche; Courtney Webster; Jennifer C Goldsack
Journal:  Digit Biomark       Date:  2021-05-18

9.  An Objective Methodology for the Selection of a Device for Continuous Mobility Assessment.

Authors:  Tecla Bonci; Alison Keogh; Silvia Del Din; Kirsty Scott; Claudia Mazzà
Journal:  Sensors (Basel)       Date:  2020-11-14       Impact factor: 3.576

Review 10.  Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective.

Authors:  Diane Stephenson; Reham Badawy; Soania Mathur; Maria Tome; Lynn Rochester
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.